IDEAS home Printed from https://ideas.repec.org/p/ohe/conres/002290.html
   My bibliography  Save this paper

Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Therapies

Author

Listed:
  • Nadine Henderson;Lotte Steuten

Abstract

Histology independent therapies, a new class of medicines that target cancer based on specific genomic or molecular alterations of cancer cells rather than tissue of origin, face significant methodological and policy hurdles related to evidence development and acceptance, value assessment and reimbursement pathways, and diagnostic infrastructure availability. To better understand the specific challenges and opportunities in various countries, we performed an in-dept analysis of (adaptive) pathways for histology independent therapies, using a combination of literature research, expert interviews and case studies. The results show that while challenges for histology independent therapies are similar in various countries, solutions will likely have to be diverse and include methodological advancements, novel payment models and decision-makers’ willingness to adopt new approaches. The report provides recommendations on each of these this to further stimulate dialogue between the various stakeholders involved.

Suggested Citation

  • Nadine Henderson;Lotte Steuten, 2020. "Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Therapies," Contract Research 002290, Office of Health Economics.
  • Handle: RePEc:ohe:conres:002290
    as

    Download full text from publisher

    File URL: https://www.ohe.org/publications/bridging-gap-pathways-regulatory-and-health-technology-assessment-histology-independent/attachment-ohe-consulting-report_-assessment-pathways-for-histology-independent-therapies_-roche-revision-2_13/
    Download Restriction: no
    ---><---

    More about this item

    Keywords

    Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Therapies;

    JEL classification:

    • I1 - Health, Education, and Welfare - - Health

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ohe:conres:002290. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Publications Manager (email available below). General contact details of provider: https://edirc.repec.org/data/ohecouk.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.